GLP-1 Medications and Disordered Eating: A Personalized, Evidence-Based Approach
Presented By:
Kim Dennis, MD
Chief Medical Officer, CEO, & Co-Founder, SunCloud HealthClinical Assistant Professor, Department of Psychiatry, University of Illinois at Chicago College of Medicine
April 26, 2024
- Understanding how GLP-1 medications work and what effect they have on different organs in the body.
- Reviewing current research data showing the benefits and risks of these medications, particularly in patients with eating disorders.
- Understanding how to implement a personalized and nuanced treatment approach for patients on GLP medications who have eating disorders and complex medical needs.
Video: Watch the Presentation
Presented by:Kim Dennis, MD, Chief Medical Officer, CEO, & Co-Founder, SunCloud Health
Clinical Assistant Professor, Department of Psychiatry, University of Illinois at Chicago College of Medicine. READ MORE on Dr. Kim’s Bio Page.
Joint Accreditation Statement:
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Galen Mental Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Video: Explaining Suncloud’s Integrated ModelWhy Is an Integrated Treatment Model Essential to Successfully Treating Patients?
Dr. Kim Dennis, Co-Founder and Medical Director at SunCloud Health, discusses the vital role the integrated model (that she is pioneering at SunCloud Health) plays in the success of treating patients with co-occurring disorders and underlying trauma. How does SunCloud create an authentic culture of patient support?